Reply to correspondence on "Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets"

doi:10.3350/cmh.2024.0320

. 2024 Oct;30(4):1037-1038.

doi: 10.3350/cmh.2024.0320. Epub 2024 May 2.

Reply to correspondence on "Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets"

Mohammad Saeid Rezaee-Zavareh¹, Naomy Kim², Ju Dong Yang^{2

3

4}

Affiliations

¹ Middle East Liver Diseases Center, Tehran, Iran.
² Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
³ Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁴ Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

PMID: 38697652
PMCID: PMC11540390
DOI: 10.3350/cmh.2024.0320

Reply to correspondence on "Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets"

Mohammad Saeid Rezaee-Zavareh et al. Clin Mol Hepatol. 2024 Oct.

. 2024 Oct;30(4):1037-1038.

doi: 10.3350/cmh.2024.0320. Epub 2024 May 2.

Authors

Mohammad Saeid Rezaee-Zavareh¹, Naomy Kim², Ju Dong Yang^{2

3

4}

Affiliations

¹ Middle East Liver Diseases Center, Tehran, Iran.
² Karsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
³ Comprehensive Transplant Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
⁴ Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

PMID: 38697652
PMCID: PMC11540390
DOI: 10.3350/cmh.2024.0320

No abstract available

Keywords: Complement system proteins; Hepatocellular carcinoma; Liver diseases; Mendelian randomization analysis.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

J.D.Y. provides a consulting service for AstraZeneca, Eisai, Exact Sciences, Exelixis, Fujifilm Medical Sciences, and Gilead Sciences. M.S.R-Z. and N.K. declare no conflict of interest.

References

1. Shi Y, Yuan G, Fan X, Xu C. Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”. Clin Mol Hepatol. 2024;30:987–988. - PMC - PubMed
1. Rezaee-Zavareh MS, Kim N, Yang JD. Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization. Clin Mol Hepatol. 2024;30:150–153. - PMC - PubMed
1. Shi Y, Dong H, Sun S, Wu X, Fang J, Zhao J, et al. Proteincentric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. Clin Mol Hepatol. 2024;30:80–97. - PMC - PubMed
1. Li L, Huang L, Yang A, Feng X, Mo Z, Zhang H, et al. Causal relationship between complement C3, C4, and nonalcoholic fatty liver disease: Bidirectional mendelian randomization analysis. Phenomics. 2021;1:211–221. - PMC - PubMed

LinkOut - more resources

Full Text Sources
- M2PI
- PubMed Central

[1] Shi Y, Yuan G, Fan X, Xu C. Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”. Clin Mol Hepatol. 2024;30:987–988. - PMC - PubMed

[2] Shi Y, Yuan G, Fan X, Xu C. Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”. Clin Mol Hepatol. 2024;30:987–988. - PMC - PubMed

[3] Rezaee-Zavareh MS, Kim N, Yang JD. Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization. Clin Mol Hepatol. 2024;30:150–153. - PMC - PubMed

[4] Rezaee-Zavareh MS, Kim N, Yang JD. Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization. Clin Mol Hepatol. 2024;30:150–153. - PMC - PubMed

[5] Shi Y, Dong H, Sun S, Wu X, Fang J, Zhao J, et al. Proteincentric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. Clin Mol Hepatol. 2024;30:80–97. - PMC - PubMed

[6] Shi Y, Dong H, Sun S, Wu X, Fang J, Zhao J, et al. Proteincentric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. Clin Mol Hepatol. 2024;30:80–97. - PMC - PubMed

[7] Li L, Huang L, Yang A, Feng X, Mo Z, Zhang H, et al. Causal relationship between complement C3, C4, and nonalcoholic fatty liver disease: Bidirectional mendelian randomization analysis. Phenomics. 2021;1:211–221. - PMC - PubMed

[8] Li L, Huang L, Yang A, Feng X, Mo Z, Zhang H, et al. Causal relationship between complement C3, C4, and nonalcoholic fatty liver disease: Bidirectional mendelian randomization analysis. Phenomics. 2021;1:211–221. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reply to correspondence on "Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets"

Affiliations

Reply to correspondence on "Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets"

Authors

Affiliations

Conflict of interest statement

Similar articles

References

LinkOut - more resources

Full Text Sources